Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 36,399 | 42,739 | 115,077 | 34,814 | 21,134 |
| Marketable Securities | 719,600 | 759,578 | 708,769 | 388,784 | 214,214 |
| Receivables | 852 | 1,534 | 2,671 | 2,628 | 252 |
| TOTAL | $778,842 | $811,975 | $835,324 | $431,693 | $245,933 |
| Non-Current Assets | |||||
| PPE Net | 4,230 | 3,864 | 4,061 | 4,060 | 4,162 |
| Intangibles | 27,190 | 27,190 | 27,190 | 27,190 | 27,190 |
| Other Non-Current Assets | 12,917 | 2,557 | 2,272 | 2,684 | 2,971 |
| TOTAL | $44,337 | $33,611 | $33,523 | $33,934 | $34,323 |
| Total Assets | $823,179 | $845,586 | $868,847 | $465,627 | $280,256 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 4,232 |
| Accounts payable and accrued liabilities | 1,114 | 3,802 | 3,234 | 3,494 | 3,586 |
| Accrued Expenses | 28,204 | 18,594 | 17,536 | 22,029 | 18,471 |
| Other current liabilities | 1,396 | 3,673 | 3,877 | 3,988 | N/A |
| TOTAL | $32,093 | $27,658 | $26,291 | $31,125 | $27,836 |
| Non-Current Liabilities | |||||
| aiOther Non-Current Liabilities | 5,181 | 4,269 | 3,943 | 5,331 | 5,702 |
| TOTAL | $5,181 | $4,269 | $3,943 | $5,331 | $5,702 |
| Total Liabilities | $37,274 | $31,927 | $30,234 | $36,456 | $33,538 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 66,344 | 66,288 | 65,911 | 55,901 | 47,264 |
| Common Shares | 66 | 66 | 66 | 56 | 47 |
| Retained earnings | -1,508,132 | -1,466,011 | -1,430,169 | -1,397,361 | -1,354,055 |
| Other shareholders' equity | 5,288 | 1,780 | 2,244 | 3,308 | 2,135 |
| TOTAL | $785,905 | $813,659 | $838,613 | $429,171 | $246,718 |
| Total Liabilities And Equity | $823,179 | $845,586 | $868,847 | $465,627 | $280,256 |